Drugs / HO/02/02
last change Dec 2014 re-read 3 minutes ago

HO/02/02

Developed for
breast cancer
Investigated by
HealOr

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT01923220 Sep 2013 → Sep 2014 breast cancer HealOr Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HO/02/02 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01923220 ↗
Route Topical “Treatment will be applied topically once daily” NCT01923220 ↗